Ausgabe 10/2022
Inhalt (34 Artikel)
Hossein Jadvar and Patrick M. Colletti (Eds): Nuclear Medicine: the Essentials
Luigi Mansi
Cervical lymph node staging in head and neck tumors: bridging the gap between humans and companion animals
Lavinia Elena Chiti, M. C. Nolff, D. Stefanello
2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe
Richard Graham, Ana P. Moreira, Andor W. J. M. Glaudemans, Lars Thorbjørn Jensen, Jasna Mihaïlovic, Sergei Nazarenko, Zehra Ozcan, Doina Piciu, Wolfgang Wadsak, Jolanta Kunikowska, François Jamar
To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment
Murat Tuncel, Alexis Vrachimis, Alfredo Campenni, Bart de Keizer, Frederik A. Verburg, Michael C. Kreissl, Petra Petranovic Ovcaricek, Tamara Geliashvili, Luca Giovanella
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging
Martina Sollini, Rodolfo Hurle, Marcello Rodari, Arturo Chiti, Massimo Lazzeri
Total-body [18F]FDG PET/CT scan has stepped into the arena: the faster, the better. Is it always true?
Luca Filippi, Orazio Schillaci
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
Stefano Fanti, Jolanta Kunikowska, Jochen Walz, Wim Witjes, Anders Bjartell
Construction and implementation of regional high-level PET alliance based on international consensus
Jianshe Yang, Zhongwei Lv
[177Lu]Lu-DOTATATE peptide receptor radionuclide therapy–associated myeloid neoplasms: insights from the WHO pharmacovigilance database
Jonathan Vigne, Basile Chrétien, Anne-Laure Bignon, Karine Bouhier-Leporrier, Charles Dolladille
Letter to the editor
David Zogala, Václav Ptáčník, Irena Maříková, Daniela Chroustová, Martin Šámal
Response to letter to the editor
David Kersting, Miriam Sraieb, Wolfgang Peter Fendler, Florian Büther, Christoph Rischpler
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
Marnix Lam, Etienne Garin, Marco Maccauro, S. Cheenu Kappadath, Daniel Y. Sze, Cuneyt Turkmen, Murat Cantasdemir, Paul Haste, Ken Herrmann, Hamad Saleh Alsuhaibani, Matthew Dreher, Kirk D. Fowers, Riad Salem
EANM guideline on quality risk management for radiopharmaceuticals
Nic Gillings, Olaug Hjelstuen, Martin Behe, Clemens Decristoforo, Philip H. Elsinga, Valentina Ferrari, Oliver C. Kiss, Petra Kolenc, Jacek Koziorowski, Peter Laverman, Thomas L. Mindt, Meltem Ocak, Marianne Patt, Sergio Todde, Almut Walte
[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease
Patrick Conen, Francesca Pennetta, Katharina Dendl, Fabian Hertel, Andreas Vogg, Uwe Haberkorn, Frederik L. Giesel, Felix M. Mottaghy
First experiences with dynamic renal [68Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate
David Kersting, Miriam Sraieb, Robert Seifert, Pedro Fragoso Costa, Sandra Kazek, Lukas Kessler, Lale Umutlu, Wolfgang Peter Fendler, Walter Jentzen, Ken Herrmann, Florian Büther, Michael Nader, Christoph Rischpler
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival
Francesco Fiz, Chiara Masci, Guido Costa, Martina Sollini, Arturo Chiti, Francesca Ieva, Guido Torzilli, Luca Viganò
The “digital biopsy” in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT
Lavinia Monaco, Elisabetta De Bernardi, Francesca Bono, Diego Cortinovis, Cinzia Crivellaro, Federica Elisei, Vincenzo L’Imperio, Claudio Landoni, Gregory Mathoux, Monica Musarra, Fabio Pagni, Elia Anna Turolla, Cristina Messa, Luca Guerra
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
Elin Trägårdh, Olof Enqvist, Johannes Ulén, Erland Hvittfeldt, Sabine Garpered, Sarah Lindgren Belal, Anders Bjartell, Lars Edenbrandt
Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [18F]FDG PET/CT study
Alberto Signore, Chiara Lauri, Marzia Colandrea, Marco Di Girolamo, Erika Chiodo, Chiara Maria Grana, Giuseppe Campagna, Antonio Aceti
Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts
Chiara Lauri, Alberto Signore, Andor W. J. M. Glaudemans, Giorgio Treglia, Olivier Gheysens, Riemer H. J. A. Slart, Roberto Iezzi, Niek H. J. Prakken, Eike Sebastian Debus, Susanne Honig, Anne Lejay, Nabil Chakfé
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
Elizabeth J. de Koster, Dennis Vriens, Maarten O. van Aken, Lioe-Ting Dijkhorst-Oei, Wim J. G. Oyen, Robin P. Peeters, Abbey Schepers, Lioe-Fee de Geus-Oei, Wilbert B. van den Hout
The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer
Jingjia Cao, Xiaolu Zhu, Yaru Sun, Xiao Li, Canhua Yun, Wei Zhang
Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with 18F-SynVesT-1 positron emission tomography imaging
Yongxiang Tang, Jie Yu, Ming Zhou, Jian Li, Tingting Long, Yulai Li, Li Feng, Dengming Chen, Zhiquan Yang, Yiyun Huang, Shuo Hu
Quantitative assessment of myelin density using [11C]MeDAS PET in patients with multiple sclerosis: a first-in-human study
Chris W. J. van der Weijden, Jan F. Meilof, Anouk van der Hoorn, Junqing Zhu, Chunying Wu, Yanming Wang, Antoon T. M. Willemsen, Rudi A. J. O. Dierckx, Adriaan A. Lammertsma, Erik F. J. de Vries
Quantification of amyloid PET for future clinical use: a state-of-the-art review
Hugh G. Pemberton, Lyduine E. Collij, Fiona Heeman, Ariane Bollack, Mahnaz Shekari, Gemma Salvadó, Isadora Lopes Alves, David Vallez Garcia, Mark Battle, Christopher Buckley, Andrew W. Stephens, Santiago Bullich, Valentina Garibotto, Frederik Barkhof, Juan Domingo Gispert, Gill Farrar
Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
Dominique Clement, Shaunak Navalkissoor, Rajaventhan Srirajaskanthan, Frédéric Courbon, Lawrence Dierickx, Amy Eccles, Valerie Lewington, Mercedes Mitjavila, Juan Carlos Percovich, Benoît Lequoy, Beilei He, Ilya Folitar, John Ramage
Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT
Yan Hu, Guobing Liu, Haojun Yu, Jianying Gu, Hongcheng Shi
Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics
Seok Kim, Ji-In Bang, Dachung Boo, Borham Kim, In Young Choi, SooJeong Ko, Ie Ryung Yoo, Kwangsoo Kim, Junmo Kim, YoungHwan Joo, Hyun Gee Ryoo, Jin Chul Paeng, Jung Mi Park, Woncheol Jang, Byungwon Kim, Yangha Chung, Dongyoon Yang, Sooyoung Yoo, Ho-Young Lee
Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection
Pascal K. C. Jonker, Madelon J. H. Metman, Luc H. J. Sondorp, Mark S. Sywak, Anthony J. Gill, Liesbeth Jansen, Thera P. Links, Paul J. van Diest, Tessa M. van Ginhoven, Clemens W. G. M. Löwik, Anh H. Nguyen, Robert P. Coppes, Dominic J. Robinson, Gooitzen M. van Dam, Bettien M. van Hemel, Rudolf S. N. Fehrmann, Schelto Kruijff
Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
Lena M. Unterrainer, Simon Lindner, Lennert Eismann, Jozefina Casuscelli, Franz-Josef Gildehaus, Vinh Ngoc Bui, Nathalie L. Albert, Adrien Holzgreve, Leonie Beyer, Andrei Todica, Matthias Brendel, Clemens C. Cyran, Alexander Karl, Christian G. Stief, Stephan T. Ledderose, Marcus Unterrainer, Peter Bartenstein, Vera Wenter, Alexander Kretschmer
Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer
Ismaheel O. Lawal, Alfred Morgenstern, Mariza Vorster, Otto Knoesen, Johncy Mahapane, Khanyisile N. Hlongwa, Letjie C. Maserumule, Honest Ndlovu, Janet D. Reed, Gbenga O. Popoola, Kgomotso M. G. Mokoala, Amanda Mdlophane, Frank Bruchertseifer, Mike M. Sathekge
First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner
Adrienne H. Brouwers, Joyce van Sluis, Johannes H. van Snick, Carolina P. Schröder, Inge O. Baas, Ronald Boellaard, Andor W. J. M. Glaudemans, Ronald J. H. Borra, Adriaan A. Lammertsma, Rudi A. J. O. Dierckx, Charalampos Tsoumpas
225Ac-DOTATATE therapy in a case of metastatic pheochromocytoma
Dengsai Peng, Hanxiang Liu, Ling Huang, Jianpeng Cao, Yue Chen
Correction to: An [18F]FDG‑PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients
David Wallis, Michaël Soussan, Maxime Lacroix, Pia Akl, Clément Duboucher, Irène Buvat